PT1173255E - Utilização de pirenoxina para a protecção de tecidos da córnea em fotoqueratectomia - Google Patents

Utilização de pirenoxina para a protecção de tecidos da córnea em fotoqueratectomia Download PDF

Info

Publication number
PT1173255E
PT1173255E PT00911259T PT00911259T PT1173255E PT 1173255 E PT1173255 E PT 1173255E PT 00911259 T PT00911259 T PT 00911259T PT 00911259 T PT00911259 T PT 00911259T PT 1173255 E PT1173255 E PT 1173255E
Authority
PT
Portugal
Prior art keywords
corneal
pyrenoxine
use according
pirenoxine
ros
Prior art date
Application number
PT00911259T
Other languages
English (en)
Portuguese (pt)
Inventor
Enrico Boldrini
Mario Ciuffi
Original Assignee
Farmigea Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmigea Spa filed Critical Farmigea Spa
Publication of PT1173255E publication Critical patent/PT1173255E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PT00911259T 1999-03-17 2000-03-13 Utilização de pirenoxina para a protecção de tecidos da córnea em fotoqueratectomia PT1173255E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000166A IT1305306B1 (it) 1999-03-17 1999-03-17 Uso della pirenoxina per la protezione dei tessuti corneali ininterventi di fotocheratectomia.

Publications (1)

Publication Number Publication Date
PT1173255E true PT1173255E (pt) 2007-03-30

Family

ID=11406570

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00911259T PT1173255E (pt) 1999-03-17 2000-03-13 Utilização de pirenoxina para a protecção de tecidos da córnea em fotoqueratectomia

Country Status (10)

Country Link
US (1) US6610686B1 (https=)
EP (1) EP1173255B1 (https=)
JP (1) JP5167499B2 (https=)
AT (1) ATE349244T1 (https=)
AU (1) AU3324100A (https=)
DE (1) DE60032594T2 (https=)
ES (1) ES2277831T3 (https=)
IT (1) IT1305306B1 (https=)
PT (1) PT1173255E (https=)
WO (1) WO2000054757A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655002B2 (en) * 1996-03-21 2010-02-02 Second Sight Laser Technologies, Inc. Lenticular refractive surgery of presbyopia, other refractive errors, and cataract retardation
US9545338B2 (en) 2006-01-20 2017-01-17 Lensar, Llc. System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser
US10842675B2 (en) 2006-01-20 2020-11-24 Lensar, Inc. System and method for treating the structure of the human lens with a laser
US9889043B2 (en) 2006-01-20 2018-02-13 Lensar, Inc. System and apparatus for delivering a laser beam to the lens of an eye
US8500723B2 (en) 2008-07-25 2013-08-06 Lensar, Inc. Liquid filled index matching device for ophthalmic laser procedures
US8480659B2 (en) 2008-07-25 2013-07-09 Lensar, Inc. Method and system for removal and replacement of lens material from the lens of an eye
US8382745B2 (en) 2009-07-24 2013-02-26 Lensar, Inc. Laser system and method for astigmatic corrections in association with cataract treatment
CA2769090A1 (en) 2009-07-24 2011-01-27 Lensar, Inc. System and method for providing laser shot patterns to the lens of an eye
US8758332B2 (en) 2009-07-24 2014-06-24 Lensar, Inc. Laser system and method for performing and sealing corneal incisions in the eye
US8617146B2 (en) 2009-07-24 2013-12-31 Lensar, Inc. Laser system and method for correction of induced astigmatism
WO2011011788A1 (en) 2009-07-24 2011-01-27 Lensar, Inc. System and method for performing ladar assisted procedures on the lens of an eye
CN102843955A (zh) 2010-02-01 2012-12-26 雷萨公司 眼科应用中吸环基于浦肯野图像的对准
USD694890S1 (en) 2010-10-15 2013-12-03 Lensar, Inc. Laser system for treatment of the eye
USD695408S1 (en) 2010-10-15 2013-12-10 Lensar, Inc. Laser system for treatment of the eye
ES3064580T3 (en) 2010-10-15 2026-04-27 Lensar Inc Scan-controlled illumination of structures within an eye
US10463541B2 (en) 2011-03-25 2019-11-05 Lensar, Inc. System and method for correcting astigmatism using multiple paired arcuate laser generated corneal incisions
EP2800812A1 (en) * 2012-01-04 2014-11-12 Quark Pharmaceuticals, Inc. Double-stranded rna compounds to casp2 and uses thereof
CN103211754A (zh) * 2012-01-19 2013-07-24 武汉诺安药业有限公司 无菌稳定的吡诺克辛钠滴眼液的生产方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2181788A1 (en) * 1994-01-21 1995-07-27 Jonathan Javitt Cis-hydroxyproline analogs for eye treatment
WO1998053806A1 (en) * 1997-05-26 1998-12-03 New Vision Co., Ltd. Medicinal compositions for topical administration containing vitamin d and vitamin k
IT1292103B1 (it) * 1997-06-06 1999-01-25 Pharmaconsult S A S Composizioni farmaceutiche topiche contenenti pirfenossone e uso dello stesso nel trattamento di condizioni infiammatorie
CN1291898A (zh) * 1998-02-25 2001-04-18 若素制药株式会社 用于角膜上皮疾病的药物

Also Published As

Publication number Publication date
ATE349244T1 (de) 2007-01-15
EP1173255B1 (en) 2006-12-27
ES2277831T3 (es) 2007-08-01
US6610686B1 (en) 2003-08-26
WO2000054757A3 (en) 2001-03-29
IT1305306B1 (it) 2001-05-04
WO2000054757A2 (en) 2000-09-21
DE60032594D1 (de) 2007-02-08
DE60032594T2 (de) 2007-10-11
EP1173255A2 (en) 2002-01-23
ITRM990166A1 (it) 2000-09-17
AU3324100A (en) 2000-10-04
JP5167499B2 (ja) 2013-03-21
JP2002539153A (ja) 2002-11-19

Similar Documents

Publication Publication Date Title
PT1173255E (pt) Utilização de pirenoxina para a protecção de tecidos da córnea em fotoqueratectomia
US6248734B1 (en) Use of photodynamic therapy for prevention of secondary cataracts
JPH05507916A (ja) 眼科用アミノステロイド
SK41593A3 (en) Using of inhibitors of plasminogene activators for the production of medicament for a therapy of ignitions and wounds
JPH0468288B2 (https=)
AU2009261285B2 (en) Peptide derivative and composition for promoting tear secretion comprising the same
MXPA05005240A (es) Imitadores de la superoxido - dismutasa para el tratamiento de desordenes y enfermedades oculares.
JP3362501B2 (ja) 角膜障害治療剤
Uner et al. Timolol-loaded ethosomes for ophthalmic delivery: Reduction of high intraocular pressure in vivo
RU2414218C1 (ru) Глазные капли для лечения дистрофических заболеваний и травм глаз
EP1370254B1 (en) Copper chelators for treating ocular inflammation
EP0815862A1 (en) Ophthalmological composition comprising activated vitamin d
JPH10500684A (ja) 非ステロイド系抗炎症性眼科用懸濁液剤
KR20070040326A (ko) 백내장, 황반 변성 및 다른 안과 질환의 개선
KR20150126021A (ko) 다이피리다몰을 이용하여 눈 장애를 치료하는데 사용하기 위한 조성물
CZ282299A3 (cs) Přípravky a nástroje pro prevenci nebo omezení účinků zánětů
US5196449A (en) Methods and pharmaceutical compositions for the treatment of ophthalmic diseases
RU2508123C1 (ru) Фармацевтическая композиция для местного применения при лечении воспалительных заболеваний глаз и способ ее использования
Artola et al. Lipid peroxidation in the iris and its protection by means of viscoelastic substances (sodium hyaluronate and hydroxypropylmethylcellulose)
RU2434633C2 (ru) Фармацевтические препаративные формы латрункулина
ITRM990719A1 (it) Uso di ubichinone q10 per il trattamento locale e la prevenzione di patalogie aftalmologiche secondarie alla terapia fotorefrattiva, chirurg
Iliaki et al. Photothrombosis of retinal and choroidal vessels in rabbit eyes using chloroaluminum sulfonated phthalocyanine and a diode laser
EP4186524A1 (en) Prevention and/or treatment of eye disease by collagen fiber crosslinking
Hull et al. Effect of oxygen free radical products on rabbit iris vascular permeability
Neuwirth‐lux et al. Vitamin E and rabbit corneal endothelial cell survival